Study title: AN 2003220170 20030626. TI Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose. AU Yuan-C-M, Spandorfer-P-R, Miller-S-L, Henretig-F-M, Shaw-L-M. IN Dr. L.M. Shaw, Clinical Toxicology Laboratory, Department of Pathology, Univ. of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104, United States e-mail: shawlmj@mail.med.upenn.edu. SO Therapeutic Drug Monitoring {THER-DRUG-MONIT}, 2003, Vol/Iss/Pg. 25/3 (299-304), ISSN: 0163-4356. YR 2003.AN 2003220170 20030626. TI Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose. AU Yuan-C-M, Spandorfer-P-R, Miller-S-L, Henretig-F-M, Shaw-L-M. IN Dr. L.M. Shaw, C...
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Behavior and Behavior Mechanisms [F01] | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CYPROHEPTADINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |